(Q41187515)

English

Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma

scientific article published on August 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

3

object named as

S M Lippman

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Frank L. Meyskens, Jr.

6

object named as

F L Meyskens

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

author name string

M R Modiano

1

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

W S Dalton

2

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

L Joffe

4

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

A R Booth

5

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

publication date

1 August 1990

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

317-319

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

https://scigraph.springernature.com/pub.10.1007/bf00171846

0 references

Tolerability of the synthetic retinoid Fenretinide (HPR)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2148744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/2148744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal retinal function associated with fenretinide, a synthetic retinoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/2148744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinoids as preventive and therapeutic anticancer agents (Part I).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2148744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2148744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2148744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00171846

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41187515&oldid=2077312333"